Iptakalim: A new or just another KCO?

Cardiovascular Research

Volumn 83, Issue 3, 2009, Pages 417-418

  Costa, Alexandre D T ^a,b  

^a INSTITUTO CARLOS CHAGAS   (Brazil)

^b Instituto de Biologia Molecular do Parana   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; DIAZOXIDE; DOBUTAMINE; ENDOTHELIN 1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.1; IPTAKALIM; NITRIC OXIDE; OUABAIN;

BLOOD VESSEL INJURY; CARDIOVASCULAR RISK; DRUG MECHANISM; EDITORIAL; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE PRESSURE; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; VASCULAR FIBROSIS;

ANIMALS; CARDIOVASCULAR AGENTS; DISEASE PROGRESSION; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FIBROSIS; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KATP CHANNELS; MICE; MYOCARDIUM; NITRIC OXIDE; PROPYLAMINES; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 67651124956     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp193     Document Type: Editorial

References (17)

1. Torok J. Participation of nitric oxide in different models of experimental hypertension. Physiol Res 2008;57:813-825.
2. van Zwieten PA. The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy. Cardiovasc Res 2000;45:82-91.
3. Wang H, Long CL, Zhang YL. A new ATP-sensitive potassium channel opener reduces blood pressure and reverses cardiovascular remodeling in experimental hypertension. J Pharmacol Exp Ther 2005;312: 1326-1333.
4. Wang H, Tang Y, Wang L, Long CL, Zhang YL. ATP-sensitive potassium channel openers and 2,3-dimethyl-2-butylamine derivatives. Curr Med Chem 2007;14:133-155.
5. ATP activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function. Cardiovasc Res 2009;83:444-456.
6. Minamino T, Hori M. Protecting endothelial function: a novel therapeutic target of ATP-sensitive potassium channel openers. Cardiovasc Res 2007; 73:448-449.
7. Wang H, Long C, Duan Z, Shi C, Jia G, Zhang Y. A new ATP-sensitive potassium channel opener protects endothelial function in cultured aortic endothelial cells. Cardiovasc Res 2007;73:497-503.
8. Xia Y, Rajapurohitam V, Cook MA, Karmazyn M. Inhibition of phenylephrine induced hypertrophy in rat neonatal cardiomyocytes by the mitochondrial KATP channel opener diazoxide. J Mol Cell Cardiol 2004;37: 1063-1067.
9. ATPin the response to inotropic stress. Am J Physiol 2006;291:H152-H160.
10. Chai Y, Niu L, Sun XL, Ding JH, Hu G. Iptakalim protects PC12 cell against H2O2-induced oxidative injury via opening mitochondrial ATPsensitive potassium channel. Biochem Biophys Res Commun 2006;350: 307-314.
11. Hu LF, Wang S, Shi XR, Yao HH, Sun YH, Ding JH et al. ATP-sensitive potassium channel opener iptakalim protected against the cytotoxicity of MPP+ on SH-SY5Y cells by decreasing extracellular glutamate level. J Neurochem 2005;94:1570-1579.
12. + channel in cardiac function and cardioprotection. Biochim Biophys Acta 2003; 1606:1-21.
13. Costa AD, Pierre SV, Cohen MV, Downey JM, Garlid KD. cGMP Signaling in Pre-and Postconditioining: The Role of Mitochondria. Cardiovasc Res 2008;77:344-352.
14. Garlid KD, Costa AD, Quinlan CL, Pierre SV, Dos Santos P. Cardioprotective signaling to mitochondria. J Mol Cell Cardiol 2009;46:858-866.
15. + channel of heart mitochondria. Am J Physiol 2001;280:H649-657.
16. ATP opening on heart mitochondria. Am J Physiol 2006;290:H406-H415.
17. Costa AD, Garlid KD. MitoK(ATP) activity in healthy and ischemic hearts. J Bioenerg Biomembr 2009;41:123-126.